Suppr超能文献

微生物组学和代谢组学揭示肠道微生物群对脂肪肝疾病肝脏再生的影响。

Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease.

作者信息

Hu Yiqing, Hu Xiaoyi, Jiang Li, Luo Jia, Huang Jiacheng, Sun Yaohan, Qiao Yinbiao, Wu Hao, Zhou Shijie, Li Haoyu, Li Jianhui, Zhou Lin, Zheng Shusen

机构信息

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, 310003, China.

Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

出版信息

EBioMedicine. 2025 Jan;111:105482. doi: 10.1016/j.ebiom.2024.105482. Epub 2024 Dec 6.

Abstract

BACKGROUND

Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with impaired regenerative capacity and poor postoperative prognosis following hepatectomy. Previous research has highlighted the importance of the gut-liver axis in the physiological and pathological processes of the liver. However, the contribution of gut bacteria to the regeneration of livers with MAFLD and its metabolic regulatory mechanisms remain elusive.

METHODS

Partial hepatectomy (PHx) was performed on C57Bl/6J mice fed with high-fat diet (HFD) for 12 weeks. Pathological examination, immunohistochemistry, and qRT-PCR analysis were performed to assess the severity of steatosis and proliferative potential. The gut microbiome was examined by 16S rRNA gene sequencing and shotgun metagenomics, whereas liver metabolomics was analysed via untargeted and targeted metabolomics using liquid chromatography-tandem mass spectrometry (LC-MS).

FINDINGS

HFD-induced hepatic steatosis in mice led to impaired liver regeneration following PHx. The gut microbiota and liver metabolites were altered along with the liver regeneration process. Longitudinal time-series analysis revealed dynamic alterations in these data, whereas correlation analysis screened out bacterial candidates that potentially influence liver regeneration in MAFLD by modulating metabolic pathways. Among these bacteria, the dominant bacterium Akkermansia was selected for subsequent investigation. MAFLD mice gavaged with Akkermansia muciniphila (A. muciniphila) exhibited reduced liver lipid accumulation and accelerated liver regeneration, possibly through the regulation of the tricarboxylic acid (TCA) cycle.

INTERPRETATION

These data demonstrated the interplay between the gut microbiome, liver metabolomics, and liver regeneration in mice with MAFLD. A. muciniphila has the potential to serve as a clinical intervention agent to accelerate postoperative recovery in MAFLD.

FUNDING

This work was supported by the Research Project of Jinan Microecological Biomedicine Shandong Laboratory [JNL-2022008B]; the Zhejiang Provincial Natural Science Foundation of China [LZ21H180001]; the Fundamental Research Funds for the Central Universities [No. 2022ZFJH003].

摘要

背景

代谢功能障碍相关脂肪性肝病(MAFLD)与肝切除术后再生能力受损及预后不良有关。以往研究强调了肠-肝轴在肝脏生理和病理过程中的重要性。然而,肠道细菌对MAFLD肝脏再生的贡献及其代谢调节机制仍不清楚。

方法

对喂食高脂饮食(HFD)12周的C57Bl/6J小鼠进行部分肝切除术(PHx)。进行病理检查、免疫组织化学和qRT-PCR分析以评估脂肪变性的严重程度和增殖潜力。通过16S rRNA基因测序和鸟枪法宏基因组学检查肠道微生物群,而使用液相色谱-串联质谱(LC-MS)通过非靶向和靶向代谢组学分析肝脏代谢组学。

研究结果

HFD诱导的小鼠肝脏脂肪变性导致PHx后肝脏再生受损。肠道微生物群和肝脏代谢物随着肝脏再生过程而改变。纵向时间序列分析揭示了这些数据的动态变化,而相关性分析筛选出了可能通过调节代谢途径影响MAFLD肝脏再生的细菌候选物。在这些细菌中,选择优势菌阿克曼氏菌进行后续研究。用嗜黏蛋白阿克曼氏菌(A.muciniphila)灌胃的MAFLD小鼠肝脏脂质积累减少,肝脏再生加速,可能是通过调节三羧酸(TCA)循环实现的。

解读

这些数据证明了MAFLD小鼠肠道微生物群、肝脏代谢组学和肝脏再生之间的相互作用。嗜黏蛋白阿克曼氏菌有潜力作为一种临床干预剂,加速MAFLD患者术后恢复。

资助

本研究得到济南微生态生物医药山东省实验室研究项目[JNL-2022008B];中国浙江省自然科学基金[LZ21H180001];中央高校基本科研业务费[No.2022ZFJH003]的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/11667181/922ea86ecaee/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验